BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20662315)

  • 1. Characterization and in vitro cellular uptake of PEG coated iron oxide nanoparticles as MRI contrast agent.
    Chen YJ; Tao J; Xiong F; Zhu JB; Gu N; Geng KK
    Pharmazie; 2010 Jul; 65(7):481-6. PubMed ID: 20662315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.
    Yue-Jian C; Juan T; Fei X; Jia-Bi Z; Ning G; Yi-Hua Z; Ye D; Liang G
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1235-44. PubMed ID: 20818962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors.
    Larsen EK; Nielsen T; Wittenborn T; Rydtoft LM; Lokanathan AR; Hansen L; Østergaard L; Kingshott P; Howard KA; Besenbacher F; Nielsen NC; Kjems J
    Nanoscale; 2012 Apr; 4(7):2352-61. PubMed ID: 22395568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
    Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
    Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
    Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
    J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity.
    LaConte LE; Nitin N; Zurkiya O; Caruntu D; O'Connor CJ; Hu X; Bao G
    J Magn Reson Imaging; 2007 Dec; 26(6):1634-41. PubMed ID: 17968941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
    Tähkä S; Laiho A; Kostiainen MA
    Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro.
    Ge Y; Zhang Y; Xia J; Ma M; He S; Nie F; Gu N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):294-301. PubMed ID: 19564099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI.
    Chen TJ; Cheng TH; Hung YC; Lin KT; Liu GC; Wang YM
    J Biomed Mater Res A; 2008 Oct; 87(1):165-75. PubMed ID: 18085650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
    Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
    Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent.
    Masoudi A; Madaah Hosseini HR; Shokrgozar MA; Ahmadi R; Oghabian MA
    Int J Pharm; 2012 Aug; 433(1-2):129-41. PubMed ID: 22579990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.
    Cowger TA; Tang W; Zhen Z; Hu K; Rink DE; Todd TJ; Wang GD; Zhang W; Chen H; Xie J
    Theranostics; 2015; 5(11):1225-32. PubMed ID: 26379788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.
    Cole AJ; David AE; Wang J; Galbán CJ; Hill HL; Yang VC
    Biomaterials; 2011 Mar; 32(8):2183-93. PubMed ID: 21176955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.
    Babic M; Horák D; Trchová M; Jendelová P; Glogarová K; Lesný P; Herynek V; Hájek M; Syková E
    Bioconjug Chem; 2008 Mar; 19(3):740-50. PubMed ID: 18288791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
    Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
    Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
    Chen YC; Chang WH; Wang SJ; Hsieh WY
    J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent.
    Nitin N; LaConte LE; Zurkiya O; Hu X; Bao G
    J Biol Inorg Chem; 2004 Sep; 9(6):706-12. PubMed ID: 15232722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
    Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
    Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
    Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
    Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.